3623 results for «2199»
3623 results
PCR e-Course 2020 Hot lines: TAVI – part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on TAVI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: PORTICO IDE, FlexNav Delivery System, FRANCE TAVI, BIVOLUT-X, VIVALL.
Revascularisation strategies - PCR e-Course 2020 Hot lines
29 Jul 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on revascularisation presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: ISIS II, REDUCER-I, RINCAL, SYNTAX score II 2020.
CT guidance for coronary interventions - PCR e-Course 2020 Hot lines
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on CT-guidance for PCI presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: CT-FFR CHINA, CAST-FFR, CT-QFR vs. myocardial perfusion imaging, CT-CTO trial, CCTA for optimal fluoroscopic coronary projections.
PCR e-Course 2020 Late-Breaking Trials - part 2
26 Jun 2020 – From PCR e-Course 2020
Watch a series of Late-Breaking Trials presented during the PCR e-Course 2020 and see how they might have an impact on your practice:
- 2-year safety of revascularisation deferral based on iFR or FFR
- CABG and PCI in patients with CTO and multivessel disease
- Routine revascularisation vs. medical therapy
PCR e-Course Hot Lines in STEMI interventions: First-in-Man and novel pharmacological strategies
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines in STEMI interventions presented during PCR e-Course 2020, followed by an analysis of these results and their impact on your practice: MOCA I Study, ON-TIME 3 trial, FABOLUS FASTER.
PCR e-Course Hot lines: drugs and devices for STEMI management
Watch this session to know more about ultrathin-strut vs thin-strut DES in patients with STEMI undergoing percutaneous coronary intervention (BIOSTEMI), RCT between bioresorbable and durable polymer stent by serial OCT assessment (MECHANISM-AMI), and the results of the FUNCOMBO trial.
Controversies in antiplatelet therapy for secondary prevention of coronary artery events
26 Jun 2020 – From PCR e-Course
Watch this session if you want to understand more about the guidelines for antiplatelet secondary prevention of ACS/PC and to review available data on antiplatelet therapy after ACS/PCI.
Physiology or intracoronary imaging; or both? or none? - part 1
27 Jun 2020 – From PCR e-Course 2020
Watch a series of studies on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SCAAR report, a sub-analysis of the FORZA trial, diagnostic accuracy of IVUS-based FFR.
Ultrathin-strut vs. thin-strut DES for primary PCI
27 Jun 2020 – From PCR e-Course 2020
Watch this session to review the role of ultrathin DES in optimising clinical outcomes for STEMI patients, to assess the impact of the BIOSTEMI trial to daily practice and to learn about real-world challenges when treating STEMI patients.
Videos included on this page: the Hot Line presentation...
PCR e-Course 2020 Hot line: left atrial appendage closure
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on LAA closure presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: LAA occlusion vs. NOAC, Amulet IDE Roll-in cohort, identification of potential LAAC candidates.
Are Lower MR Grades Within Our "Clasp"? – PASCAL Repair System Experience
Watch this session to know more about the transcatheter PASCAL Repair System for the treatment of mitral regurgitation and its clinical and commercial experience.
Physiology or intracoronary imaging; or both? or none? - part 2
27 Jun 2020 – From PCR e-Course 2020
Watch a series of Hot Lines on physiology and intracoronary imaging presented during the PCR e-Course 2020, followed by an analysis of the results and their impact on your practice: SOCT-PCI Study, impact of PPG index on PCI, angiography-derived IMR.
Treating tricuspid regurgitation with the PASCAL repair system
Watch this roundtable discussion on the treatment of tricuspid regurgitation with the recently approved in Europe PASCAL Repair System.
How the interventional cardiologist should approach patients with a vasculogenic erectile dysfunction?
Watch this roundtable discussion if you want to learn how cardiologist should approach the patients with erectile dysfunction and to see how to treat a patient with ED with Sirolimus Coated Balloon
CT guidance for coronary intervention and surgery
27 Jun 2020 – From PCr e-Course 2020
Find out how coronary CT can be used for selection of coronary revascularisation procedures and how it can help planning the procedural strategy for PCI of bifurcation and complex lesions.
This session was originally presented during PCR e-Course 2020.
Essentials of intracoronary imaging: the best use of your 50 probes
27 Jun 2020 – From PCR e-Course 2020
Watch this session to learn more about the best use of intracoronary imaging in clinical practice and answer the following questions:
- For which patient?
- For which procedure?
- When does intracoronary imaging improve PCI result?
- When does intracoronary imaging improve patient outcome?
This session was originally presented during PCR e-Course 2020.
Prevention and management of complications during valvular and structural interventions
26 Jun 2020 – From PCR e-Course 2020
Watch this case discussion to understand how to avoid complications, to assess how to recognise complications early and to identify how to handle complications scenarios.
This session was originally presented during PCR e-Course 2020.
Innovative solutions to treat diabetic patients
Watch this video if you want to understand the need of dedicated DES for Diabetes Mellitus (DM) patients, to understand and learn the differences of CAD for diabetic compared to non-diabetic patients, to see clinical evidences and results for the treatment of Diabetic patients with DES+...
TAVI: Full one-year Evolut low-risk randomised results and economic implications
EVOLUT Low Risk Trial of self-expanding TAVI versus SAVR: discover the key take-aways from the economic analysis as well as the health economics implications to understand the potential drivers for TAVI cost-effectives in Europe.
Videos included on this page: the Hot Line presentation and an Investigator Perspective.
Case Based Learning for the Heart Team: coronary artery disease in TAVI patients
25 Jun 2020 – From PCR e-Course 2020
Watch this case discussion to understand the practical implications of coronary artery disease in TAVI patients, to recognise different situations where this interaction directly impacts on clinical outcomes and to appreciate how to apply this information in your daily clinical practice.
This session was originally presented during...
